Drug Profile
IDN 5243
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Indena
- Class Analgesics; Colchicum alkaloids; Monosaccharides
- Mechanism of Action Inflammation mediator inhibitors; Muscle protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Back pain; Pain
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Back-pain(In volunteers) in Italy (IM)
- 30 Mar 2018 Indena terminates phase II trial in Back pain in Italy (NCT02568826)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in Italy (Intraperitoneal)